|
Oct 3
|
High Growth Tech Stocks In Australia Featuring 3 Promising Picks
|
|
Sep 30
|
CLINUVEL files Canadian New Drug Submission for SCENESSE® in EPP
|
|
Nov 27
|
Clinuvel Pharmaceuticals Limited's (ASX:CUV) largest shareholders are retail investors with 59% ownership, institutions own 20%
|